Does MOSUNETUZUMAB-AXGB Cause Off label use? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Off label use have been filed in association with MOSUNETUZUMAB-AXGB. This represents 10.1% of all adverse event reports for MOSUNETUZUMAB-AXGB.
20
Reports of Off label use with MOSUNETUZUMAB-AXGB
10.1%
of all MOSUNETUZUMAB-AXGB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Off label use From MOSUNETUZUMAB-AXGB?
Of the 20 reports, 2 (10.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOSUNETUZUMAB-AXGB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does MOSUNETUZUMAB-AXGB Cause?
Cytokine release syndrome (52)
Pyrexia (27)
Disease progression (25)
Rash (18)
No adverse event (16)
Neutropenia (13)
Thrombocytopenia (9)
Chills (8)
Fatigue (8)
Death (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which MOSUNETUZUMAB-AXGB Alternatives Have Lower Off label use Risk?
MOSUNETUZUMAB-AXGB vs MOXIFLOXACIN
MOSUNETUZUMAB-AXGB vs MOXIFLOXACIN\MOXIFLOXACIN
MOSUNETUZUMAB-AXGB vs MOXONIDINE
MOSUNETUZUMAB-AXGB vs MS CONTIN
MOSUNETUZUMAB-AXGB vs MULTAQ